GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Biocartis Group NV (CHIX:BCARTb) » Definitions » Margin of Safety % (DCF FCF Based)

Biocartis Group NV (CHIX:BCARTB) Margin of Safety % (DCF FCF Based) : N/A (As of Jun. 14, 2025)


View and export this data going back to 2016. Start your Free Trial

What is Biocartis Group NV Margin of Safety % (DCF FCF Based)?

Margin of Safety % (DCF FCF Based) = (Intrinsic Value: DCF (FCF Based) - Current Price) / Intrinsic Value: DCF (FCF Based).

Note: Discounted FCF model is only suitable for predictable companies (Business Predictability Rank higher than 1-Star). If the company's Predictability Rank is 1-Star or Not Rated, result may not be accurate due to the low predictability of business and the data will not be stored into our database.

Biocartis Group NV's Predictability Rank is Not Rated. Thus, the DCF related results in the screener and portfolio will appear as zero and Margin of Safety % (DCF FCF Based) is not calculated.


Competitive Comparison of Biocartis Group NV's Margin of Safety % (DCF FCF Based)

For the Diagnostics & Research subindustry, Biocartis Group NV's Margin of Safety % (DCF FCF Based), along with its competitors' market caps and Margin of Safety % (DCF FCF Based) data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Biocartis Group NV's Margin of Safety % (DCF FCF Based) Distribution in the Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, Biocartis Group NV's Margin of Safety % (DCF FCF Based) distribution charts can be found below:

* The bar in red indicates where Biocartis Group NV's Margin of Safety % (DCF FCF Based) falls into.


;
;

Biocartis Group NV Margin of Safety % (DCF FCF Based) Related Terms

Thank you for viewing the detailed overview of Biocartis Group NV's Margin of Safety % (DCF FCF Based) provided by GuruFocus.com. Please click on the following links to see related term pages.


Biocartis Group NV Business Description

Traded in Other Exchanges
N/A
Address
Generaal de Wittelaan 11 B, Mechelen, BEL, 2800
Biocartis Group NV is a commercial-stage molecular diagnostics company. It provides diagnostic solutions aimed at improving clinical practice for patients, clinicians, payers, and the industry. The firm has developed an MDx Idylla molecular diagnostic system for oncology and infectious disease segments. Its products include EGFR mutation assay, BRAF mutation test, NRAS mutation test, respiratory panel, etc. The firm derives the majority of its revenues from product sales.

Biocartis Group NV Headlines

No Headlines